Therefore, the purpose of the present study was to identify miR-125a-3p as a new anti-oncogene, which regulates FUT5 and FUT6 and affects aberrant activation of the PI3K/Akt pathway in CRC. The gene discussed is FUT6; the disease is colorectal carcinoma.